Stocks
GSK plcGSK
NYSEHealthcarePharmaceuticals$53.39-1.64%
A global pharmaceutical leader known for developing vaccines and prescription medicines, including treatments for respiratory diseases and HIV. Investors monitor GSK for its pipeline of innovative drugs and stable dividend payments.
Market Cap: $107.1B52W Range: $32.38 – $61.70
Congressional Interest in GSK plc (GSK)
7 members of Congress have disclosed 50 trades in GSK plc (GSK), a Healthcare company. The buy/sell breakdown shows 24 purchases versus 26 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
7
Buys
24
Sells
26
Who in Congress Is Trading GSK?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-04-06 | DAN BENISHEK | buy | $15K – $50K |
| 2015-04-06 | DAN BENISHEK | buy | $1K – $15K |